We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Alector
ALEC
$203M
| – | – |
-300,000
| Closed | -$7.33M |
|
752
Artivion
AORT
$1.29B
| – | – |
-200,000
| Closed | -$3.83M |
|
753
Algonquin Power & Utilities
AQN
$4.43B
| – | – |
-2,650,000
| Closed | -$34.3M |
|
754
Arcturus Therapeutics
ARCT
$173M
| – | – |
-100,000
| Closed | -$4.67M |
|
755
Ascendis Pharma A/S
ASND
$16.4B
| – | – |
-30,000
| Closed | -$4.44M |
|
756
AptarGroup
ATR
$8.63B
| – | – |
-375,000
| Closed | -$42M |
|
757
Armstrong World Industries
AWI
$7.78B
| – | – |
-63,423
| Closed | -$4.94M |
|
758
Axalta
AXTA
$8.03B
| – | – |
-100,000
| Closed | -$2.25M |
|
759
Beam Therapeutics
BEAM
$2.81B
| – | – |
-358,000
| Closed | -$10M |
|
760
BILL Holdings
BILL
$4.68B
| – | – |
-10,000
| Closed | -$902K |
|
|
BLUE
761
DELISTED
bluebird bio
BLUE
| – | – |
-28,940
| Closed | -$22.9M |
|
762
Crown Holdings
CCK
$13.2B
| – | – |
-929,052
| Closed | -$60.5M |
|
763
Coherus Oncology
CHRS
$194M
| – | – |
-125,000
| Closed | -$2.23M |
|
764
Cincinnati Financial
CINF
$27.5B
| – | – |
-72,100
| Closed | -$4.62M |
|
|
CLLS
765
Cellectis
CLLS
$271M
| – | – |
-300,000
| Closed | -$5.34M |
|
766
Clean Energy Fuels
CLNE
$410M
| – | – |
-300,000
| Closed | -$666K |
|
767
Compass Minerals
CMP
$1.08B
| – | – |
-70,491
| Closed | -$3.44M |
|
768
Coty
COTY
$2.39B
| – | – |
-322,944
| Closed | -$1.44M |
|
769
Curtiss-Wright
CW
$26.4B
| – | – |
-58,799
| Closed | -$5.25M |
|
770
Quest Diagnostics
DGX
$26.3B
| – | – |
-153,100
| Closed | -$17.4M |
|
771
Euronet Worldwide
EEFT
$2.73B
| – | – |
-50,000
| Closed | -$4.79M |
|
772
Enovis
ENOV
$1.51B
| – | – |
-304,109
| Closed | -$14.6M |
|
773
EPAM Systems
EPAM
$4.86B
| – | – |
-25,000
| Closed | -$6.3M |
|
774
Equitable Holdings
EQH
$14.2B
| – | – |
-350,000
| Closed | -$6.75M |
|
775
Eversource Energy
ES
$27.1B
| – | – |
-367,582
| Closed | -$30.6M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.